Nebenwirkungen · Cresemba
CRESEMBA 40 mg hard capsules CRESEMBA 100 mg hard capsules · Abschnitt 4.8 · PDF-Seite 36–37
HOS-129010 · Präparat HOS-096645
36 Vascular disorders Common Thrombophlebitis^ Uncommon Circulatory collapse; Hypotension Respiratory, thoracic and mediastinal disorders Common Dyspnoea^; Acute respiratory failure^ Uncommon Bronchospasm; Tachypnoea; Haemoptysis; Epistaxis Gastrointestinal disorders Common Vomiting; Diarrhoea; Nausea; Abdominal pain^ Uncommon Dyspepsia; Constipation; Abdominal distension Hepatobiliary disorders Common Elevated liver chemistry tests^# Uncommon Hepatomegaly; Hepatitis Skin and subcutaneous tissue disorders Common Rash^; Pruritus Uncommon Petechiae; Alopecia; Drug eruption; Dermatitis^ Musculoskeletal and connective tissue disorders Uncommon Back pain Renal and urinary disorders Common Renal failure General disorders and administration site conditions Common Chest pain^; Fatigue Uncommon Oedema peripheral^; Malaise; Asthenia ^ Indicates that grouping of appropriate preferred terms into a single medical concept occurred. * ADR identified post-marketing. # See section Description of selected adverse reactions below.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-24T19:07:53Z · SHA-256 717f0eaf344e7731233baaa73335921f17bfdd86e9fa04c8f2a3921c343e8f3d · Passage a84cbb53cc462e8d897bb1ccbd31a845a79c985bd88d2970f9958ddb15280224 · Zeichen 2394–3612 im Abschnitt